One of our Rheumatologists who reads more than I do has asked for an
availability and costing for Anti-CPP as a rheumatological marker (see
attached pdf). Does anyone have a laboratory line on this please ?
with best wishes
Queen Mary's Hospital
From: yasser elmiedany [mailto:[log in to unmask]]
Sent: 04 December 2003 15:47
To: Andrew Bamji
Subject: Re: Anit-CCP
thank you for your email.
Over the past year (2002) several research studies were
published about early arthritis and how to manage it. Some of
the studies were conducted in UK by David Scott and Paul Emery.
Separate supplements have been published in J. Rheumatology,
Clinical and Experimental Rheumatology discussing that issue in
review articles. Anti-CCP has been found more specific than RF
from the diagnostic point of view and better in predicting the
course of arthritis, specially early arthritis. Please find
attached a small and quick review published by the American
College of Rheumatology on 3rd of October 03.
I look forward to seeing you.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
List Instructions (How to leave etc.)